Načítá se...
Vinflunine in the treatment of advanced urothelial cancer: clinical evidence and experience
Vinflunine (VFL) has been approved in Europe for second-line treatment of metastatic and advanced urothelial cancer after failure of platin-containing therapy. Since approval, the drug has been investigated in few clinical trials. Most of the currently available reports describe experiences with VFL...
Uloženo v:
| Vydáno v: | Ther Adv Urol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5167074/ https://ncbi.nlm.nih.gov/pubmed/28042310 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287216677903 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|